The effects of long term monolayer culture on the proteoglycan phenotype of a clonal population of mature human malignant chondrocytes.
Articular cartilage chondrocytes maintain biosynthetic heterogeneity in cell culture, but undergo irreversible dedifferentiation of their proteoglycan phenotype, as defined by keratan sulfate content. A recently described cell line of malignant human chondrocytes, 105KC, was the first to maintain a differentiated keratan sulfate-proteoglycan phenotype in long-term culture. A clone of 105KC, labeled KC2H3, is currently described and represents a distinct and metabolically more homogeneous population of mature chondrocytes than 105KC. KC2H3 cells universally express keratan sulfate biosynthesis, as defined by indirect immunofluorescence. In addition, KC2H3 expresses a more mature proteoglycan phenotype than 105KC, as demonstrated by the keratan sulfate content: 24% of glycosaminoglycan content of the aggregating proteoglycans of KC2H3 versus 13% for 105KC. Further reported are the effects of long term monolayer culture on the proteoglycan phenotype expressed by KC2H3. After more than 16 months in continuous monolayer, KC2H3 cells remained morphologically indistinguishable from those maintained in suspension alternating with monolayer. In addition, the proteoglycan phenotype remained mature, without a tendency towards dedifferentiation. The flattened morphology adopted by chondrocytes while in monolayer has been considered a stimulus of dedifferentiation; the present study is the first to examine the direct effects of physical state on a homogeneous and stable population of chondrocytes.
Block
J A
JA
Department of Internal Medicine (Rheumatology), Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612-3864.
Inerot
S E
SE
Gitelis
S
S
Kimura
J H
JH
D002809:Chondroitin Sulfates / Q000032:analysis; D002813:Chondrosarcoma / Q000737:chemistry* / Q000473:pathology; D002999:Clone Cells; D005109:Extracellular Matrix / Q000737:chemistry; D006025:Glycosaminoglycans / Q000032:analysis*; D006801:Humans; D007632:Keratan Sulfate / Q000032:analysis; D009024:Morphogenesis / Q000502:physiology*; D010641:Phenotype; D011509:Proteoglycans / Q000032:analysis*; D014407:Tumor Cells, Cultured / Q000473:pathology
D006025:Glycosaminoglycans; D011509:Proteoglycans; D002809:Chondroitin Sulfates; D007632:Keratan Sulfate